Related Experiment Video
Updated: Mar 24, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex
F Garibaldi1, E Falcone1, D Trisciuoglio1
1Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, Regina Elena National Cancer Institute, Rome, Italy.
Abstract:
Downregulation of microRNAs (miRNAs) is commonly observed in cancers and promotes tumorigenesis suggesting that miRNAs may function as tumor suppressors. However, the mechanism through which miRNAs are regulated in cancer, and the connection between oncogenes and miRNA biogenesis remain poorly understood. The TP53 tumor-suppressor gene is mutated in half of human cancers resulting in an oncogene with gain-of-function activities. Here we demonstrate that mutant p53 (mutp53) oncoproteins modulate the biogenesis of a subset of miRNAs in cancer cells inhibiting their post-transcriptional maturation. Interestingly, among these miRNAs several are also downregulated in human tumors. By confocal, co-immunoprecipitation and RNA-chromatin immunoprecipitation experiments, we show that endogenous mutp53 binds and sequesters RNA helicases p72/82 from the microprocessor complex, interfering with Drosha-pri-miRNAs association. In agreement with this, the overexpression of p72 leads to an increase of mature miRNAs levels. Moreover, functional experiments demonstrate the oncosuppressive role of mutp53-dependent miRNAs (miR-517a, -519a, -218, -105). Our study highlights a previously undescribed mechanism by which mutp53 interferes with Drosha-p72/82 association leading, at least in part, to miRNA deregulation observed in cancer.
Insights
Mutant p53 (mutp53) oncoproteins disrupt microRNA (miRNA) biogenesis in cancer by sequestering RNA helicases. This leads to decreased mature miRNA levels and promotes tumor suppressor roles for these miRNAs.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- MicroRNAs (miRNAs) are often downregulated in cancers, suggesting tumor suppressor functions.
- The mechanisms regulating miRNAs in cancer and their link to oncogenes are not fully understood.
- Mutations in the TP53 gene create mutant p53 (mutp53) oncoproteins with gain-of-function activities.
Purpose of the Study:
- To investigate how mutant p53 (mutp53) oncoproteins affect microRNA (miRNA) biogenesis in cancer.
- To elucidate the molecular mechanisms underlying miRNA deregulation by mutp53.
- To determine the functional significance of mutp53-modulated miRNAs in tumorigenesis.
Main Methods:
- Confocal microscopy, co-immunoprecipitation, and RNA-chromatin immunoprecipitation were used to study protein-RNA interactions.
- Assays were performed to assess the impact of p72 overexpression on mature miRNA levels.
- Functional experiments were conducted to evaluate the tumor-suppressive roles of specific miRNAs.
Main Results:
- Mutant p53 (mutp53) oncoproteins inhibit the post-transcriptional maturation of a subset of microRNAs (miRNAs) in cancer cells.
- Endogenous mutp53 binds and sequesters RNA helicases p72/82 from the microprocessor complex, disrupting Drosha-pri-miRNA association.
- Overexpression of p72 increased mature miRNA levels, and several mutp53-downregulated miRNAs exhibited tumor-suppressive functions.
Conclusions:
- Mutant p53 (mutp53) interferes with Drosha-p72/82 association, representing a novel mechanism for miRNA deregulation in cancer.
- This interference contributes to the reduced levels of tumor-suppressive miRNAs observed in various human cancers.
- Targeting this mutp53-mediated pathway could offer new therapeutic strategies for cancer treatment.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
MicroRNAs
piRNA - Piwi-interacting RNAs
Negative Regulator Molecules

